Study summary

In this study all patients will be treated with the same medicine, the QUTENZA patch. Subjects will receive up to 6 QUTENZA patch applications over 12 months.

Additional Study Details

Phase
4
Product
N/A
Product
QUTENZA
Type
Interventional
Masking
None (Open Label)
Enrollment number
306
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for Safety and effectiveness of repeated administration of QUTENZA patches for treatment of pain caused by nerve damage? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    London, United Kingdom, SE1 7EH
    Completed
    Edegem, Belgium, 2650
    Completed
    Ferrol, Spain, 15405
    Completed
    Liverpool, United Kingdom, L97LJ
    Withdrawn
    Almada, Portugal, 2800-525
    Withdrawn
    Amadora, Portugal, 2700
    Completed
    Vienna, Austria, 1090
    Completed
    Helsinki, Finland, 00280
    Completed
    Roma, Italy, 00149
    Completed
    Naples, Italy, 80131
    Completed
    Antwerpen, Belgium, 2000
    Completed
    London, United Kingdom, E11BB
    Completed
    Rimini, Italy, 47900
    Completed
    Granada, Spain, 18014
    Completed
    Edinburgh, United Kingdom, EH4 2XU
    Completed
    London, United Kingdom, SW17 0QT
    Withdrawn
    Krakow, Poland, 31-531
    Completed
    Plzen-Lochotin, Czech Republic, 304 60
    Withdrawn
    Parma, Italy, 43100
    Withdrawn
    Valencia, Spain, 46014
    Completed
    Nice, France, 06002
    Withdrawn
    Athens, Greece, 11527
    Completed
    Warsawa, Poland, 00-416
    Completed
    Glasgow, United Kingdom, G12 0YN
    Completed
    Malaga, Spain, 29010
    Completed
    Solihull, United Kingdom, B91 2LJ
    Completed
    Rionero in Vulture, Italy, 85028
    Completed
    Tampere, Finland, 33100
    Completed
    Prague 5, Czech Republic, 150 06
    Completed
    Nieuwegein, Netherlands, 3435
    Withdrawn
    Wroclaw, Poland, 50-240
    Withdrawn
    Lodz, Poland, 90-238
    Withdrawn
    Coimbra, Portugal, 3000-075
    Completed
    Paris, France, 75012
    Completed
    Athens, Greece, 54642
    Completed
    Bratislava, Slovakia, 85107
    Completed
    Cork, Ireland
    Completed
    Roeselare, Belgium, 8800
    Completed
    Bydgoszcz, Poland, 85-094
    Completed
    Zwolle, Netherlands, 8011
    Completed
    Brno-Bohunice, Czech Republic, 625 00
    Completed
    Pavia, Italy, 27100
    Completed
    Boulogne Billancourt, France, 92100
    Completed
    Katowice, Poland, 40-662
    Completed
    Jesenice, Slovenia, 4270
    Completed
    Barakaldo, Spain, 48903
    Completed
    Taormina, Italy, 98039
    Completed
    Athens, Greece, 11528
    Completed
    Genk, Belgium, 3600
    Completed
    Saint - Etienne Cedex 2, France, 42055
    Completed
    Bucuresti, Romania
    Completed
    Badalona, Spain, 08025
    Completed
    Madrid, Spain, 28006
    Completed
    Barcelona, Spain, 08035
    Completed
    Ljubljana, Slovenia, 1000
    Completed
    Vienna, Austria, 1160
    Completed
    Cataluna, Spain, 8025
    Completed
    Prague, Czech Republic, 180 81
    Withdrawn
    Latina, Italy, 04100
    Completed
    Lodz, Poland, 94-238
    Completed
    Madrid, Spain, 28034
    Completed
    Palermo, Italy, 90146
    Completed
    Paris Cedex 13, France, 75651
    Withdrawn
    Lisbon, Portugal, 1150
    Completed
    London, United Kingdom, SW10 9NH
    Completed
    Paris, France, 75018
    Completed
    Barcelona, Spain, 8025
    Withdrawn
    Bratislava, Slovakia
    Completed
    Salamanca, Spain, 37007
    Completed
    Milan, Italy, 20132
    Completed
    Chieti, Italy, 66100
    Completed
    Brussels, Belgium, 1000
    Completed
    Dublin, Ireland, 9
    Completed
    Brighton, United Kingdom, BN2 1ES
    Withdrawn
    Tampere, Finland, 33520
    Completed
    Pecs, Hungary, 7623
    Completed
    Timisoara, Romania, 300723

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?